The peptide activates extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation in a dose-dependent manner, leading to nuclear translocation and activation of transcription factors including c-Fos, c-Jun, and early growth response-1 (Egr-1) that drive expression of genes involved in cell growth, migration, and angiogenesis
Phase 2: Maintenance Phase (Weeks 58) TB-500 dosing drops back once the loading phase is complete
The muscle must be easy to reach
Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airways
Understanding what to expect and how to manage symptoms keeps your protocol on track
They are, at best, an adjunct one that might offer significant benefit for carefully selected patients under qualified medical supervision